Professor Long R Jiao
Professor of Surgery and Consultant Hepato-Pancreatico-Biliary Surgeon, The Royal Marsden Hospital
Speaker's biography
Professor of Surgery, Chair of Hepato-Pancreatico-Biliary (HPB) Surgery, The Royal Marsden Hospital, Imperial College, London, UK. He is the lead for Robotic HPB surgery at Royal Marsden Hospital, formally at the Hammersmith Hospital before moving to the Royal Marsden Hospital to set up robotic HPB surgery, two national and internationally renowned institutes for HPB cancer and surgery. He presented and published the first clinical paper on radiofrequency ablation at IHPBA meeting in Madrid in 1998. He has built a strong translational research team focusing on microRNAs in pancreatic cancer for early diagnosis of pancreatic cancer, the molecular biology of circulating tumour cells in liver and pancreatic cancer, and liver regeneration. For the first time, he described CTCs residing in organs local to pancreatic or colon cancers and identified 3 mRNAs to differentiate benign from premalignant pancreatic cystic tumours for early detection of pancreatic cancer. His clinical interest and expertise are in surgical innovation and minimum invasive liver and pancreatic surgery having established the first Robotic HPB programme in the UK and performed a large number of laparoscopic and robotic pancreatic and liver operation including the 1st laparoscopic and Robotic Whipple’s operation and robotic synchronous resection in the UK. In liver surgery, he introduced radiofrequency-assisted liver partition with portal vein ligation for staged liver resection (RALPPS) to increase the number of patients for liver surgery who would be otherwise considered not resectable by inducing liver hypertrophy preoperatively to avoid postoperative liver failure. In pancreatic surgery, he described longitudinal pancreatojejunostomy following Whipple’s for pancreatic reconstruction, and laparoscopic Long’s sleeve pancreaticogastrostomy (LPG) for central pancreatectomy to preserve pancreas and spleen. He has over 200 publications including high IF journals in Nature, The Lancet Oncology, the Journal of Clinical Oncology, Gastroenterology, JAMA surgery and Annals of Surgery.